Vitamin C vs Zinc for Colds — what the trials actually show
Both are stockpiled in medicine cabinets every winter; both are routinely overpromised on supplement labels. The clinical literature is unusually clear here because two Cochrane reviews have synthesised it. Vitamin C does not prevent colds in the general adult population, and only modestly shortens duration when taken daily — its main "preventive" signal is in people under unusual physical stress. Zinc lozenges, started within 24 hours of symptom onset at the right dose and salt, can meaningfully shorten cold duration. The two are not interchangeable, and most consumers buy the wrong product for the use case.
Quick verdict
| Goal | Better choice | Why |
|---|---|---|
| Shorten an already-started cold | Zinc lozenges | Cochrane 2024 finds zinc lozenges started within 24 hours shorten cold duration by ~1–2 days on average at total daily doses ≥75 mg of elemental zinc. |
| Prevent colds (general adult) | Neither, really | Cochrane 2023 update of vitamin C found no preventive effect in the general population. Daily zinc has a weak preventive signal in some pediatric trials but not adults. |
| Reduce colds in extreme physical stress (marathoners, soldiers, skiers) | Vitamin C | Hemilä's subgroup analyses consistently show ~50% reduction in cold incidence in this specific population at 200–1000 mg/day. Not generalisable to office workers. |
| Pregnancy / lactation use | Vitamin C | Vitamin C at standard doses (≤200 mg/day) is well tolerated; high-dose zinc lozenges are not characterised in pregnancy and can deplete copper. |
| Kids with frequent colds | Zinc (paediatric dosing) | Paediatric zinc trials in deficient or marginal populations show meaningful reductions in cold incidence and severity. Lozenges are not appropriate; syrup or chewables are. |
| Cost-conscious choice | Zinc lozenges | A single bout of cold-shortening zinc costs roughly the price of one OTC cold-medicine box. Daily vitamin C is cheap but you take it indefinitely. |
How they compare on the things that matter
Mechanism — antioxidant vs antiviral
Vitamin C is a water-soluble antioxidant and cofactor for collagen synthesis. The cold rationale rests on its role in neutrophil function and a presumed dampening of oxidative damage during respiratory infection. In trials, daily supplementation does measurably raise plasma ascorbate, but the translation to clinical cold endpoints is weak in the general population.
Zinc lozenges work through a more proximal mechanism: dissolved zinc ions in the oropharynx appear to interfere directly with rhinovirus binding and replication on contact, and may also blunt local inflammatory cytokine release. This is why the lozenge form matters — swallowed zinc capsules don't deliver ions to the upper airway and do not show the same duration-shortening effect.
Evidence base by endpoint
- Cold prevention (general adults): Hemilä & Chalker 2023 Cochrane update — vitamin C does not reduce cold incidence in the general population. Daily zinc in adults has not been convincingly shown to prevent colds.
- Cold prevention (heavy physical stress): Same Cochrane review — vitamin C does reduce cold incidence by about half in marathoners, soldiers, and subarctic exercisers. This is a narrow population.
- Cold duration: Vitamin C taken daily produces an ~8% reduction in adult cold duration and ~14% in children — small but real. Zinc lozenges started within 24 hours at total daily doses ≥75 mg shorten duration by 1–2 days (Hemilä 2017 / Cochrane 2024 update).
- Cold severity: Modest evidence for zinc; weak evidence for vitamin C.
- Other respiratory infections: Neither has compelling evidence for influenza, COVID-19, or non-rhinovirus URIs.
Dose and form
Vitamin C: 200–1000 mg/day daily. There's no compelling dose-response above 1 g; absorption saturates and the rest is excreted. Liposomal and "high-bioavailability" forms are not necessary for cold endpoints. Most evidence is on plain ascorbic acid.
Zinc: the critical detail is the lozenge form, the salt, and the elemental zinc dose. Zinc acetate and zinc gluconate lozenges work when total elemental zinc reaches ≥75 mg/day, split across 4–6 lozenges spaced 2–3 hours apart, held in the mouth to dissolve slowly. Zinc citrate and orotate capsules do not reproduce the lozenge effect. Stop after 5–7 days — chronic high-dose zinc depletes copper.
Safety
Vitamin C is well tolerated up to about 2 g/day; above that, GI upset and theoretical oxalate-related kidney stone risk in susceptible individuals. There is a small interaction with iron absorption (it enhances non-heme iron uptake — generally desirable, but to be aware of in hemochromatosis).
Zinc lozenges commonly cause nausea, dysgeusia (altered taste), and a metallic mouth — these resolve when use stops. Intranasal zinc preparations should not be used: they have been linked to permanent anosmia and were withdrawn from the US market. Chronic zinc >40 mg/day suppresses copper absorption — not a concern for 5–7 day cold protocols but a real issue for daily "immune support" regimens.
What the price difference buys you
Both are cheap supplements. The cost trap is paying premium prices for proprietary "immune blends" that combine sub-therapeutic doses of vitamin C, zinc, elderberry, and echinacea — which often delivers neither a real zinc lozenge dose nor a meaningful vitamin C intake. For cold-shortening, buy a stand-alone zinc acetate or zinc gluconate lozenge with the elemental zinc dose clearly listed per lozenge.
Who should skip each
Vitamin C should be approached cautiously by people with recurrent calcium-oxalate kidney stones, hemochromatosis, or glucose-6-phosphate dehydrogenase (G6PD) deficiency at very high doses. Daily megadosing (≥3 g/day) is not supported by evidence and increases GI side effects.
Zinc lozenges should be avoided in people on copper-containing medications, in those with conditions requiring sustained zinc >40 mg/day, and during pregnancy/lactation where the lozenge dose pattern hasn't been characterised. People on certain antibiotics (fluoroquinolones, tetracyclines) should separate dosing by 2 hours because zinc chelates these drugs.
What we'd actually buy
For a household cold-defence kit: zinc acetate or zinc gluconate lozenges with ≥13 mg elemental zinc per lozenge, sealed in a bottle and used only at first symptoms. Take one every 2–3 waking hours for the first 24 hours, total ≥75 mg/day, taper after the cold breaks, stop by day 7.
For endurance athletes in heavy training: plain ascorbic acid 500 mg once daily during the season. The signal is real in this population but does not generalise.
For everyone else: skip the daily vitamin C; keep zinc lozenges on hand for when a cold actually starts.
Sources
- Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;(1):CD000980 (updated 2023). PMID: 23440782
- Hemilä H, Petrus EJ, Fitzgerald JT, Prasad A. Zinc acetate lozenges for treating the common cold: an individual patient data meta-analysis. Br J Clin Pharmacol. 2016;82(5):1393–1398. PMID: 27378206
- Hemilä H. Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage. JRSM Open. 2017;8(5):2054270417694291. PMID: 28515951
- Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev. 2013;(6):CD001364. PMID: 23775705
- Wang MX, Win SS, Pang J. Zinc supplementation reduces common cold duration among healthy adults: a systematic review of randomized controlled trials. Am J Trop Med Hyg. 2020;103(1):86–99. PMID: 32342851
- Abioye AI, Bromage S, Fawzi W. Effect of micronutrient supplements on influenza and other respiratory tract infections among adults: a systematic review and meta-analysis. BMJ Glob Health. 2021;6(1):e003176. PMID: 33472840